oxazolidin-2-one has been researched along with arachidonic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andou, T; Fujimoto, J; Hara, R; Hayashi, R; Iida, K; Imanishi, M; Kawamoto, T; Kubo, K; Maekawa, T; Masada, S; Matsui, J; Matsunaga, N; Miyahisa, I; Nagase, H; Noguchi, N; Okamoto, R; Takagahara, S; Tamura, YO; Tohyama, K | 1 |
1 other study(ies) available for oxazolidin-2-one and arachidonic acid
Article | Year |
---|---|
Discovery of 3,5-Diphenyl-4-methyl-1,3-oxazolidin-2-ones as Novel, Potent, and Orally Available Δ-5 Desaturase (D5D) Inhibitors.
Topics: Administration, Oral; Animals; Arachidonic Acid; Atherosclerosis; Biological Availability; Delta-5 Fatty Acid Desaturase; Drug Discovery; Fatty Acid Desaturases; Liver; Mice; Oxazolidinones; Structure-Activity Relationship | 2017 |